Conservative Versus Liberal Red Cell Transfusion in Acute Myocardial Infarction (the CRIT Randomized Pilot Study)

被引:202
作者
Cooper, Howard A. [1 ]
Rao, Sunil V. [2 ]
Greenberg, Michael D. [3 ]
Rumsey, Maria P. [1 ]
McKenzie, Marcus [1 ]
Alcorn, Kirsten W. [1 ]
Panza, Julio A. [1 ]
机构
[1] Washington Hosp Ctr, Washington, DC 20010 USA
[2] Durham VA Med Ctr, Durham, NC USA
[3] DC VA Med Ctr, Washington, DC USA
关键词
BLOOD-TRANSFUSION; CLINICAL-TRIAL; REQUIREMENTS; OUTCOMES;
D O I
10.1016/j.amjcard.2011.06.014
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Red blood cell transfusion is common in patients with acute myocardial infarction (AMI). However, observational data suggest that this practice may be associated with worse clinical outcomes and data from clinical trials are lacking in this population. We conducted a prospective multicenter randomized pilot trial in which 45 patients with AMI and a hematocrit level <= 30% were randomized to a liberal (transfuse when hematocrit <30% to maintain 30% to 33%) or a conservative (transfuse when hematocrit <24% to maintain 24% to 27%) transfusion strategy. Baseline hematocrit was similar in those in the liberal and conservative arms (26.9% vs 27.5%, p = 0.4). Average daily hematocrits were 30.6% in the liberal arm and 27.9% in the conservative arm, a difference of 2.7% (p <0.001). More patients in the liberal arm than in the conservative arm were transfused (100% vs 54%, p <0.001) and the average number of units transfused per patient tended to be higher in the liberal arm than in the conservative arm (2.5 vs 1.6, p = 0.07). The primary clinical safety measurement of in-hospital death, recurrent MI, or new or worsening congestive heart failure occurred in 8 patients in the liberal arm and 3 in the conservative arm (38% vs 13%, p = 0.046). In conclusion, compared to a conservative transfusion strategy, treating anemic patients with AMI according to a liberal transfusion strategy results in more patients receiving transfusions and higher hematocrit levels. However, this may be associated with worse clinical outcomes. A large-scale definitive trial addressing this issue is urgently required. (C) 2011 Elsevier Inc. All rights reserved. (Am J Cardiol 2011;108:1108-1111)
引用
收藏
页码:1108 / 1111
页数:4
相关论文
共 9 条
[1]
Clinical Trial Opportunities in Transfusion Medicine: Proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium [J].
Blajchman, Morris A. ;
Glynn, Simone A. ;
Josephson, Cassandra D. ;
Kleinman, Steve H. .
TRANSFUSION MEDICINE REVIEWS, 2010, 24 (04) :259-285
[2]
Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS) [J].
Carson, Jeffrey L. ;
Terrin, Michael L. ;
Magaziner, Jay ;
Chaitman, Bernard R. ;
Apple, Fred S. ;
Heck, David A. ;
Sanders, David .
TRANSFUSION, 2006, 46 (12) :2192-2206
[3]
Transfusion Requirements After Cardiac Surgery The TRACS Randomized Controlled Trial [J].
Hajjar, Ludhmila A. ;
Vincent, Jean-Louis ;
Galas, Filomena R. B. G. ;
Nakamura, Rosana E. ;
Silva, Carolina M. P. ;
Santos, Marilia H. ;
Fukushima, Julia ;
Kalil Filho, Roberto ;
Sierra, Denise B. ;
Lopes, Neuza H. ;
Mauad, Thais ;
Roquim, Aretusa C. ;
Sundin, Marcia R. ;
Leao, Wanderson C. ;
Almeida, Juliano P. ;
Pomerantzeff, Pablo M. ;
Dallan, Luis O. ;
Jatene, Fabio B. ;
Stolf, Noedir A. G. ;
Auler, Jose O. C., Jr. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (14) :1559-1567
[4]
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? [J].
Hébert, PC ;
Yetisir, E ;
Martin, C ;
Blajchman, MA ;
Wells, G ;
Marshall, J ;
Tweeddale, M ;
Pagliarello, G ;
Schweitzer, I .
CRITICAL CARE MEDICINE, 2001, 29 (02) :227-234
[5]
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care [J].
Hébert, PC ;
Wells, G ;
Blajchman, MA ;
Marshall, J ;
Martin, C ;
Pagliarello, G ;
Tweeddale, M ;
Schweitzer, I ;
Yetisir, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :409-417
[6]
Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention [J].
Jolicoeur, E. Marc ;
O'Neill, William W. ;
Hellkamp, Anne ;
Hamm, Christian W. ;
Holmes, David R., Jr. ;
Al-Khalidi, Hussein R. ;
Patel, Manesh R. ;
Van de Werf, Frans J. ;
Pieper, Karen ;
Armstrong, Paul W. ;
Granger, Christopher B. .
EUROPEAN HEART JOURNAL, 2009, 30 (21) :2575-2583
[7]
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes [J].
Rao, SV ;
Jollis, JG ;
Harrington, RA ;
Granger, CB ;
Newby, LK ;
Armstrong, PW ;
Moliterno, DJ ;
Lindblad, L ;
Pieper, K ;
Topol, EJ ;
Stamler, JS ;
Califf, RM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (13) :1555-1562
[8]
Blood transfusion in elderly patients with acute myocardial infarction. [J].
Wu, WC ;
Rathore, SS ;
Wang, Y ;
Radford, MJ ;
Krumholz, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (17) :1230-1236
[9]
The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes - Results from the CRUSADE National Quality Improvement Initiative [J].
Yang, G ;
Alexander, KP ;
Chen, AY ;
Roe, MT ;
Brindis, RG ;
Rao, SV ;
Gibler, WB ;
Ohman, EM ;
Peterson, ED .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (08) :1490-1495